Main > ONCOLOGY (**) > Pancreas Cancer>MET *** > Treatment > Co: KR. G. Tertomotide HCl Inj.++> > +Gemcitabine
Gemcitabine: 1000mg/mē Gemcitabine must be given intravenously over 30minutes on day 1,8,15 followed by 7days s rest from the beginning of 1st day of Tertomotide administration. This cycle is repeated every 4 weeks. In such cases, dose reduction or delay prescription according to the patient s progression of adverse event refers to Gemcitabine labeling information.
+Gemcitabine's products
This section has no products